Neuroectodermal influence in odontogenic cyst and tumor: Evidence through CD56 immunoexpression

Area of Science:

• Oral pathology
• Immunohistochemistry
• Neuroectodermal differentiation

Background:

• CD56 is a marker for neural lineage and neuroectodermal differentiation.
• Odontogenic keratocysts (OKCs) exhibit aggressive behavior and high recurrence rates.
• Previous studies reported high CD56 immunoreactivity in OKCs.

Purpose of the Study:

• To analyze CD56 immunoexpression in ameloblastoma (AM) and OKC.
• To investigate the neuroectodermal influence in the pathogenesis of these odontogenic lesions.
• To correlate CD56 expression with clinicopathologic parameters.

Main Methods:

• Immunohistochemical analysis of CD56 was performed.
• Fifty cases of OKC and AM were studied (25 each from tooth-bearing and molar-ramus regions).
• Five dental follicular tissues served as controls.

Main Results:

• CD56 immunopositivity was observed in 64% of AM and 36% of OKC cases.
• AM showed cytoplasmic expression in peripheral cells of odontogenic islands.
• OKC displayed continuous cytoplasmic expression in basal and parabasal cells of the cystic lining.

Conclusions:

• CD56 immunoexpression in AM and OKC may indicate neuroectodermal influence in their pathogenesis.
• CD56 expression might influence the clinical behavior and aggressiveness of odontogenic lesions.
• Correlating CD56 expression with clinical outcomes could aid in prognostic assessment.